SESSION TITLE: Lung Cancer III
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Lung Cancer continues to be the leading cause of cancer related mortality worldwide. Recent technological advances can detect ubiquitous and heterogeneous tumor mutation variants in blood samples from patients with lung cancer. However, qualitative validation is necessary in order to implement utility of such tests in clinical practice. In this study, we hypothesize that tumor derived circulating DNA can be used to detect tumor specific mutation in non-small cell lung cancer (NSCLC).